tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market

Marksans Pharma Limited (MARKSANS) Financial Statements

Compare
4 Followers

Marksans Pharma Limited Financial Overview

Marksans Pharma Limited's market cap is currently ₹78.83B. The company's EPS TTM is ₹2.2; its P/E ratio is 22.41; and it has a dividend yield of 0.44%. Marksans Pharma Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 26.23B₹ 21.77B₹ 18.52B₹ 14.80B₹ 13.68B
Gross Profit₹ 14.79B₹ 11.03B₹ 9.31B₹ 7.32B₹ 7.50B
Operating Income₹ 11.29B₹ 3.87B₹ 3.00B₹ 5.17B₹ 5.48B
EBITDA₹ 5.29B₹ 5.09B₹ 3.99B₹ 3.01B₹ 3.46B
Net Income₹ 3.81B₹ 3.14B₹ 2.66B₹ 1.85B₹ 2.39B
Balance Sheet
Cash & Short-Term Investments₹ 7.05B₹ 7.00B₹ 7.19B₹ 3.47B₹ 2.12B
Total Assets₹ 32.40B₹ 26.81B₹ 21.90B₹ 16.40B₹ 12.28B
Total Debt₹ 3.22B₹ 2.44B₹ 1.23B₹ 1.11B₹ 341.02M
Net Debt₹ -3.82B₹ -1.59B₹ -2.59B₹ -2.35B₹ -1.75B
Total Liabilities₹ 7.50B₹ 5.95B₹ 4.25B₹ 4.17B₹ 3.23B
Stockholders' Equity₹ 24.67B₹ 20.65B₹ 17.45B₹ 12.02B₹ 8.86B
Cash Flow
Free Cash Flow₹ 337.45M₹ 215.69M₹ 1.84B₹ 529.27M₹ 1.32B
Operating Cash Flow₹ 2.07B₹ 2.30B₹ 2.37B₹ 992.57M₹ 1.79B
Investing Cash Flow₹ -490.09M₹ -1.41B₹ -2.59B₹ -416.86M₹ -448.96M
Financing Cash Flow₹ -651.46M₹ -687.27M₹ 1.98B₹ 795.11M₹ -152.86M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History

Marksans Pharma Limited Debt to Assets

Marksans Pharma Limited Cash Flow

Marksans Pharma Limited Forecast EPS vs Actual EPS